Jasper Dingemanse, PhD, PharmD, FCP

Jasper Dingemanse studied pharmacy and pharmacology and has been group leader CNS clinical pharmacology at F. Hoffmann-La Roche, Scientific Director at The Medicines Company, and Head Clinical Pharmacology at Actelion and Idorsia Pharmaceuticals. Further, he has worked as Project Leader and Scientific Director in 2 different Phase 1 CROs. Since early 2024 he is a consultant in the field of early clinical development and the transition between preclinical and clinical. He is the author of approximately 400 publications in the field of preclinical and clinical pharmacology.